| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.991 | 0.003 | 0.991 | Antiinflammatory | 0.979 0.004 DBMET02133 0.974 0.004 DBMET02134 | ||
| 0.955 | 0.004 | 0.955 | Toll-Like receptor agonist | 0.854 0.005 DBMET02133 0.773 0.005 DBMET02134 | ||
| 0.955 | 0.004 | 0.955 | Toll-Like receptor 7 agonist | 0.857 0.005 DBMET02133 0.78 0.005 DBMET02134 | ||
| 0.856 | 0.009 | 0.917 | Transcription factor NF kappa B inhibitor | 0.917 0.005 DBMET02133 0.856 0.009 DBMET02134 | DBMET02133 | |
| 0.78 | 0.001 | 0.78 | Glucocorticoid agonist | 0.623 0.001 DBMET02133 0.727 0.001 DBMET02134 | ||
| 0.627 | 0.002 | 0.736 | Lipocortins synthesis antagonist | 0.656 0.002 DBMET02133 0.736 0.001 DBMET02134 | DBMET02134 | |
| 0.598 | 0.013 | 0.69 | Immunosuppressant | 0.662 0.007 DBMET02133 0.69 0.005 DBMET02134 | DBMET02134 | |
| 0.57 | 0.009 | 0.824 | Hypoxia-inducible factor 1 alpha inhibitor | 0.786 0.003 DBMET02133 0.824 0.003 DBMET02134 | DBMET02134 | |
| 0.535 | 0 | 0.535 | Corticosteroid-like | 0.37 0.001 DBMET02133 0.272 0.001 DBMET02134 | ||
| 0.504 | 0.004 | 0.788 | Antipruritic | 0.788 0.003 DBMET02133 0.741 0.003 DBMET02134 | DBMET02133 | |
| 0.49 | 0.005 | 0.49 | Platelet adhesion inhibitor | 0.208 0.067 DBMET02133 | ||
| 0.51 | 0.038 | 0.528 | Antibacterial | 0.528 0.033 DBMET02133 0.337 0.11 DBMET02134 | DBMET02133 | |
| 0.429 | 0.01 | 0.491 | Sodium/bile acid cotransporter inhibitor | 0.453 0.007 DBMET02133 0.491 0.004 DBMET02134 | DBMET02134 | |
| 0.486 | 0.079 | 0.704 | Apoptosis agonist | 0.646 0.04 DBMET02133 0.704 0.03 DBMET02134 | DBMET02134 | |
| 0.405 | 0 | 0.443 | Arachidonic acid antagonist | 0.443 0 DBMET02133 0.389 0 DBMET02134 | DBMET02133 | |
| 0.404 | 0.01 | 0.632 | Interferon gamma antagonist | 0.538 0.004 DBMET02133 0.632 0.002 DBMET02134 | DBMET02134 | |
| 0.404 | 0.028 | 0.404 | DNA damaging | 0.163 0.154 DBMET02133 0.171 0.143 DBMET02134 | ||
| 0.388 | 0.014 | 0.746 | Diuretic | 0.724 0.004 DBMET02133 0.746 0.003 DBMET02134 | DBMET02134 | |
| 0.378 | 0.008 | 0.378 | Alkylator | 0.216 0.022 DBMET02133 0.205 0.025 DBMET02134 | ||
| 0.383 | 0.027 | 0.587 | Nitric oxide antagonist | 0.451 0.02 DBMET02133 0.587 0.01 DBMET02134 | DBMET02134 | |
| 0.361 | 0.01 | 0.557 | NOS3 expression enhancer | 0.557 0.004 DBMET02133 0.517 0.005 DBMET02134 | DBMET02133 | |
| 0.366 | 0.021 | 0.58 | Anesthetic general | 0.58 0.005 DBMET02133 0.377 0.02 DBMET02134 | DBMET02133 | |
| 0.35 | 0.021 | 0.471 | P-glycoprotein inhibitor | 0.471 0.01 DBMET02133 0.405 0.016 DBMET02134 | DBMET02133 | |
| 0.293 | 0.003 | 0.54 | Glucocorticoid antagonist | 0.362 0.002 DBMET02133 0.54 0.002 DBMET02134 | DBMET02134 | |
| 0.275 | 0.004 | 0.275 | Microtubule formation inhibitor | 0.248 0.009 DBMET02133 0.214 0.017 DBMET02134 | ||
| 0.336 | 0.071 | 0.652 | Cholesterol antagonist | 0.628 0.015 DBMET02133 0.652 0.012 DBMET02134 | DBMET02134 | |
| 0.266 | 0.003 | 0.625 | Aldosterone antagonist | 0.453 0.002 DBMET02133 0.625 0.001 DBMET02134 | DBMET02134 | |
| 0.263 | 0.015 | 0.325 | Topoisomerase I inhibitor | 0.325 0.009 DBMET02133 | DBMET02133 | |
| 0.286 | 0.048 | 0.286 | Antimitotic | |||
| 0.224 | 0.003 | 0.726 | Anabolic | 0.282 0.001 DBMET02133 0.726 0.001 DBMET02134 | DBMET02134 | |
| 0.245 | 0.028 | 0.474 | Lipid peroxidase inhibitor | 0.337 0.014 DBMET02133 0.474 0.006 DBMET02134 | DBMET02134 | |
| 0.283 | 0.068 | 0.42 | Antioxidant | 0.4 0.035 DBMET02133 0.42 0.032 DBMET02134 | DBMET02134 | |
| 0.216 | 0.001 | 0.249 | Lipocortins synthesis agonist | 0.23 0.001 DBMET02133 0.249 0.001 DBMET02134 | DBMET02134 | |
| 0.267 | 0.065 | 0.267 | Platelet antagonist | |||
| 0.206 | 0.013 | 0.676 | Androgen antagonist | 0.366 0.005 DBMET02133 0.676 0.003 DBMET02134 | DBMET02134 | |
| 0.203 | 0.013 | 0.235 | Antineoplastic alkaloid | 0.163 0.024 DBMET02133 0.235 0.006 DBMET02134 | DBMET02134 | |
| 0.187 | 0.005 | 0.709 | Androgen agonist | 0.32 0.003 DBMET02133 0.709 0.001 DBMET02134 | DBMET02134 | |
| 0.186 | 0.027 | 0.303 | Farnesoid X receptor antagonist | 0.241 0.013 DBMET02133 0.303 0.005 DBMET02134 | DBMET02134 | |
| 0.151 | 0.003 | 0.168 | Progesterone agonist | 0.092 0.004 DBMET02133 0.168 0.003 DBMET02134 | DBMET02134 | |
| 0.179 | 0.031 | 0.179 | Cell adhesion inhibitor | |||
| 0.204 | 0.063 | 0.345 | Hepatoprotectant | 0.275 0.037 DBMET02133 0.345 0.02 DBMET02134 | DBMET02134 | |
| 0.148 | 0.012 | 0.197 | Interleukin 5 antagonist | 0.165 0.008 DBMET02133 0.197 0.005 DBMET02134 | DBMET02134 | |
| 0.15 | 0.021 | 0.166 | Toll-Like receptor 4 antagonist | 0.166 0.014 DBMET02133 0.14 0.027 DBMET02134 | DBMET02133 | |
| 0.139 | 0.012 | 0.308 | Estrogen agonist | 0.206 0.008 DBMET02133 0.308 0.005 DBMET02134 | DBMET02134 | |
| 0.139 | 0.015 | 0.619 | Aromatase inhibitor | 0.314 0.005 DBMET02133 0.619 0.003 DBMET02134 | DBMET02134 | |
| 0.126 | 0.004 | 0.132 | Nitric oxide donor | 0.132 0.003 DBMET02133 0.11 0.005 DBMET02134 | DBMET02133 | |
| 0.123 | 0.005 | 0.227 | RNA-directed RNA polymerase stimulant | 0.144 0.004 DBMET02133 0.227 0.003 DBMET02134 | DBMET02134 | |
| 0.143 | 0.026 | 0.309 | Estrogen antagonist | 0.183 0.015 DBMET02133 0.309 0.006 DBMET02134 | DBMET02134 | |
| 0.24 | 0.13 | 0.353 | Interleukin 2 agonist | 0.296 0.076 DBMET02133 0.353 0.044 DBMET02134 | DBMET02134 | |
| 0.113 | 0.007 | 0.312 | Mineralocorticoid receptor antagonist | 0.156 0.005 DBMET02133 0.312 0.004 DBMET02134 | DBMET02134 | |
| 0.108 | 0.003 | 0.108 | Protein 30S ribosomal subunit inhibitor | 0.061 0.006 DBMET02133 0.023 0.019 DBMET02134 | ||
| 0.131 | 0.032 | 0.178 | Breast cancer-resistant protein inhibitor | 0.178 0.017 DBMET02133 0.115 0.043 DBMET02134 | DBMET02133 | |
| 0.101 | 0.01 | 0.463 | 5-Alpha-reductase inhibitor | 0.317 0.003 DBMET02133 0.463 0.001 DBMET02134 | DBMET02134 | |
| 0.163 | 0.072 | 0.379 | Interleukin 6 antagonist | 0.215 0.033 DBMET02133 0.379 0.008 DBMET02134 | DBMET02134 | |
| 0.095 | 0.008 | 0.125 | Heme oxygenase stimulant | 0.105 0.006 DBMET02133 0.125 0.004 DBMET02134 | DBMET02134 | |
| 0.095 | 0.009 | 0.201 | Estrogen receptor alpha agonist | 0.122 0.006 DBMET02133 0.201 0.004 DBMET02134 | DBMET02134 | |
| 0.199 | 0.125 | 0.515 | DNA synthesis inhibitor | 0.352 0.03 DBMET02133 0.515 0.012 DBMET02134 | DBMET02134 | |
| 0.075 | 0.005 | 0.075 | Microtubule stabilization | 0.067 0.008 DBMET02133 0.056 0.02 DBMET02134 | ||
| 0.101 | 0.038 | 0.152 | Transcription factor NF kappa B stimulant | 0.123 0.024 DBMET02133 0.152 0.015 DBMET02134 | DBMET02134 | |
| 0.07 | 0.012 | 0.458 | Progesterone antagonist | 0.223 0.004 DBMET02133 0.458 0.002 DBMET02134 | DBMET02134 | |
| 0.121 | 0.064 | 0.362 | Cholesterol synthesis inhibitor | 0.236 0.02 DBMET02133 0.362 0.006 DBMET02134 | DBMET02134 | |
| 0.067 | 0.014 | 0.067 | Liver X receptor agonist | |||
| 0.091 | 0.04 | 0.138 | Na+ K+ transporting ATPase inhibitor | 0.116 0.019 DBMET02133 0.138 0.009 DBMET02134 | DBMET02134 | |
| 0.103 | 0.059 | 0.154 | Estrogen receptor beta antagonist | 0.117 0.036 DBMET02133 0.154 0.015 DBMET02134 | DBMET02134 | |
| 0.048 | 0.013 | 0.068 | Glucose-6-phosphate dehydrogenase inhibitor | 0.053 0.01 DBMET02133 0.068 0.005 DBMET02134 | DBMET02134 | |
| 0.042 | 0.009 | 0.122 | Estrone sulfatase inhibitor | 0.06 0.006 DBMET02133 0.122 0.004 DBMET02134 | DBMET02134 | |
| 0.169 | 0.14 | 0.392 | Immunostimulant | 0.392 0.052 DBMET02133 0.32 0.073 DBMET02134 | DBMET02133 | |
| 0.062 | 0.038 | 0.071 | Beta tubulin antagonist | 0.071 0.034 DBMET02133 | DBMET02133 | |
| 0.112 | 0.097 | 0.184 | Interleukin 4 antagonist | 0.136 0.065 DBMET02133 0.184 0.028 DBMET02134 | DBMET02134 | |
| 0.016 | 0.002 | 0.285 | Transcortin receptor antagonist | 0.035 0.001 DBMET02133 0.285 0 DBMET02134 | DBMET02134 | |
| 0.122 | 0.109 | 0.122 | Hemostatic | |||
| 0.149 | 0.14 | 0.751 | Aldehyde oxidase inhibitor | 0.506 0.032 DBMET02133 0.751 0.005 DBMET02134 | DBMET02134 | |
| 0.027 | 0.024 | 0.152 | Estrogen receptor beta agonist | 0.069 0.016 DBMET02133 0.152 0.007 DBMET02134 | DBMET02134 | |
| 0.068 | 0.066 | 0.122 | Antineoplastic antibiotic | 0.086 0.053 DBMET02133 0.122 0.038 DBMET02134 | DBMET02134 | |
| 0.094 | 0.092 | 0.201 | DNA polymerase I inhibitor | 0.142 0.054 DBMET02133 0.201 0.028 DBMET02134 | DBMET02134 | |
| 0.011 | 0.012 | 0.014 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.012 0.009 DBMET02133 0.014 0.005 DBMET02134 | DBMET02134 | |
| 0.097 | 0.103 | 0.598 | Interleukin 8 antagonist | 0.19 0.015 DBMET02133 0.598 0.003 DBMET02134 | DBMET02134 | |
| 0.076 | 0.094 | 0.094 | Thioredoxin inhibitor | 0.094 0.056 DBMET02133 | DBMET02133 | |
| 0.095 | 0.114 | 0.162 | Bone formation stimulant | 0.162 0.051 DBMET02133 0.149 0.06 DBMET02134 | DBMET02133 | |
| 0.013 | 0.033 | 0.312 | 5-Alpha-reductase 2 inhibitor | 0.133 0.004 DBMET02133 0.312 0.002 DBMET02134 | DBMET02134 | |
| 0.008 | 0.035 | 0.243 | 5-Alpha-reductase 1 inhibitor | 0.071 0.006 DBMET02133 0.243 0.003 DBMET02134 | DBMET02134 | |
| 0.181 | 0.208 | 0.411 | Apoptosis antagonist | 0.322 0.072 DBMET02133 0.411 0.035 DBMET02134 | DBMET02134 | |
| 0.063 | 0.091 | 0.233 | Estrogen receptor alpha antagonist | 0.092 0.033 DBMET02133 0.233 0.007 DBMET02134 | DBMET02134 | |
| 0.013 | 0.05 | 0.093 | Squalene synthetase inhibitor | 0.083 0.008 DBMET02133 0.093 0.007 DBMET02134 | DBMET02134 | |
| 0.133 | 0.171 | 0.23 | Free radical scavenger | 0.204 0.095 DBMET02133 0.23 0.078 DBMET02134 | DBMET02134 | |
| 0.065 | 0.103 | 0.589 | Monophenol monooxygenase inhibitor | 0.293 0.019 DBMET02133 0.589 0.005 DBMET02134 | DBMET02134 | |
| 0.048 | 0.101 | 0.08 | Topoisomerase II alpha inhibitor | 0.08 0.053 DBMET02133 | DBMET02133 | |
| 0.007 | 0.06 | 0.248 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.248 0.003 DBMET02134 | DBMET02134 | |
| 0.103 | 0.157 | 0.259 | Angiogenesis stimulant | 0.193 0.098 DBMET02133 0.259 0.066 DBMET02134 | DBMET02134 | |
| 0.011 | 0.065 | 0.019 | Progesterone receptor B antagonist | 0.019 0.014 DBMET02134 | DBMET02134 | |
| 0.139 | 0.2 | 0.246 | Hypoglycemic | 0.246 0.079 DBMET02133 | DBMET02133 | |
| 0.015 | 0.077 | 0.02 | Vitamin D receptor antagonist | 0.02 0.019 DBMET02134 | DBMET02134 | |
| 0.067 | 0.129 | 0.08 | Vanilloid agonist | 0.08 0.072 DBMET02133 | DBMET02133 | |
| 0.007 | 0.089 | 0.018 | Telomerase stimulant | 0.018 0.01 DBMET02134 | DBMET02134 | |
| 0.008 | 0.104 | 0.062 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.062 0.007 DBMET02134 | DBMET02134 | |
| 0.094 | 0.206 | 0.306 | Melanin inhibitor | 0.144 0.091 DBMET02133 0.306 0.021 DBMET02134 | DBMET02134 | |
| 0.012 | 0.139 | 0.192 | Estradiol 17 beta-dehydrogenase inhibitor | 0.192 0.005 DBMET02134 | DBMET02134 | |
| 0.086 | 0.213 | 0.153 | Growth hormone agonist | 0.153 0.085 DBMET02134 | DBMET02134 | |
| 0.01 | 0.138 | 0.076 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.076 0.005 DBMET02134 | DBMET02134 | |
| 0.101 | 0.245 | 0.226 | Vasodilator | 0.226 0.085 DBMET02133 | DBMET02133 | |
| 0.132 | 0.282 | 0.312 | Antithrombotic | 0.276 0.106 DBMET02133 0.312 0.081 DBMET02134 | DBMET02134 | |
| 0.044 | 0.197 | 0.108 | Topoisomerase II inhibitor | 0.108 0.078 DBMET02133 | DBMET02133 | |
| 0.113 | 0.273 | 0.359 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.194 0.077 DBMET02133 0.359 0.011 DBMET02134 | DBMET02134 | |
| 0.084 | 0.246 | 0.291 | Hypolipemic | 0.269 0.059 DBMET02133 0.291 0.052 DBMET02134 | DBMET02134 | |
| 0.065 | 0.23 | 0.153 | Neurotrophic factor | 0.153 0.056 DBMET02134 | DBMET02134 | |
| 0.05 | 0.216 | 0.361 | AMP-activated protein kinase stimulant | 0.181 0.014 DBMET02133 0.361 0.004 DBMET02134 | DBMET02134 | |
| 0.022 | 0.189 | 0.077 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.077 0.017 DBMET02134 | DBMET02134 | |
| 0.025 | 0.197 | 0.072 | Glucose-6-phosphate translocase inhibitor | 0.065 0.019 DBMET02133 0.072 0.015 DBMET02134 | DBMET02134 | |
| 0.05 | 0.232 | 0.096 | ABCA1 expression enhancer | 0.096 0.056 DBMET02134 | DBMET02134 | |
| 0.015 | 0.199 | 0.036 | Hedgehog signaling activator | 0.036 0.006 DBMET02134 | DBMET02134 | |
| 0.042 | 0.226 | 0.09 | UDP-glucose 4-epimerase inhibitor | 0.09 0.073 DBMET02133 | DBMET02133 | |
| 0.089 | 0.276 | 0.261 | Neurotrophic factor enhancer | 0.17 0.11 DBMET02133 0.261 0.032 DBMET02134 | DBMET02134 | |
| 0.037 | 0.224 | 0.115 | Glycine receptor agonist | 0.066 0.064 DBMET02133 0.115 0.014 DBMET02134 | DBMET02134 | |
| 0.078 | 0.268 | 0.164 | Adenylate cyclase stimulant | 0.124 0.114 DBMET02133 0.164 0.042 DBMET02134 | DBMET02134 | |
| 0.083 | 0.276 | 0.22 | Tumour necrosis factor alpha release inhibitor | 0.212 0.099 DBMET02133 0.22 0.093 DBMET02134 | DBMET02134 | |
| 0.034 | 0.242 | 0.106 | Expectorant | 0.099 0.069 DBMET02133 0.106 0.062 DBMET02134 | DBMET02134 | |
| 0.03 | 0.239 | 0.143 | Glycine receptor antagonist | 0.143 0.009 DBMET02134 | DBMET02134 | |
| 0.043 | 0.254 | 0.193 | Beta glucuronidase inhibitor | 0.193 0.014 DBMET02134 | DBMET02134 | |
| 0.036 | 0.258 | 0.067 | Glutamate (mGluR6) antagonist | 0.067 0.047 DBMET02134 | DBMET02134 | |
| 0.035 | 0.259 | 0.095 | Keratolytic | 0.069 0.066 DBMET02133 0.095 0.034 DBMET02134 | DBMET02134 | |
| 0.025 | 0.271 | 0.067 | Pregnane X receptor antagonist | 0.067 0.018 DBMET02134 | DBMET02134 | |
| 0.101 | 0.35 | 0.151 | Ca2+-transporting ATPase inhibitor | 0.151 0.039 DBMET02134 | DBMET02134 | |
| 0.037 | 0.29 | 0.102 | Mucolytic | 0.097 0.082 DBMET02133 0.102 0.075 DBMET02134 | DBMET02134 | |
| 0.058 | 0.315 | 0.304 | Interleukin antagonist | 0.304 0.047 DBMET02134 | DBMET02134 | |
| 0.037 | 0.296 | 0.117 | Bile acid receptor antagonist | 0.087 0.081 DBMET02133 0.117 0.023 DBMET02134 | DBMET02134 | |
| 0.005 | 0.268 | 0.077 | Farnesoid X receptor agonist | 0.036 0.028 DBMET02133 0.077 0.005 DBMET02134 | DBMET02134 | |
| 0.017 | 0.281 | 0.059 | Neuraminidase (influenza) inhibitor | 0.059 0.056 DBMET02133 | DBMET02133 | |
| 0.05 | 0.319 | 0.086 | T cell inhibitor | 0.086 0.047 DBMET02134 | DBMET02134 | |
| 0.035 | 0.313 | 0.131 | Thrombolytic | 0.131 0.098 DBMET02133 0.123 0.107 DBMET02134 | DBMET02133 | |
| 0.056 | 0.337 | 0.189 | Spasmolytic | 0.189 0.129 DBMET02133 | DBMET02133 | |
| 0.046 | 0.346 | 0.078 | Estrogen-related receptor beta agonist | 0.078 0.075 DBMET02134 | DBMET02134 | |
| 0.109 | 0.453 | 0.689 | Cyclophilin D inhibitor | 0.497 0.051 DBMET02133 0.689 0.015 DBMET02134 | DBMET02134 | |
| 0.034 | 0.393 | 0.193 | Adenylate cyclase inhibitor | 0.193 0.027 DBMET02134 | DBMET02134 | |
| 0.008 | 0.368 | 0.051 | HIV-1 integrase (Strand Transfer) inhibitor | 0.051 0.049 DBMET02134 | DBMET02134 | |
| 0.006 | 0.4 | 0.041 | GABA uptake inhibitor | 0.041 0.025 DBMET02134 | DBMET02134 | |
| 0.044 | 0.484 | 0.101 | Interleukin 2 antagonist | 0.101 0.09 DBMET02134 | DBMET02134 | |
| 0.03 | 0.48 | 0.139 | Cytokine production inhibitor | 0.139 0.071 DBMET02134 | DBMET02134 | |
| 0.043 | 0.509 | 0.161 | Phospholipase C inhibitor | 0.161 0.085 DBMET02134 | DBMET02134 | |
| 0.078 | 0.608 | 0.445 | Caspase 9 stimulant | 0.445 0.086 DBMET02134 | DBMET02134 | |
| 0.032 | 0.58 | 0.213 | Transcription factor STAT3 inhibitor | 0.213 0.118 DBMET02134 | DBMET02134 | |
| 0.057 | 0.632 | 0.218 | Calcium channel activator | 0.218 0.188 DBMET02134 | DBMET02134 | |
| 0.023 | 0.605 | 0.127 | Pregnane X receptor agonist | 0.127 0.108 DBMET02134 | DBMET02134 | |
| 0.03 | 0.626 | 0.174 | Interleukin agonist | 0.174 0.145 DBMET02134 | DBMET02134 | |
| 0.049 | 0.665 | 0.194 | Caspase 3 stimulant | 0.194 0.178 DBMET02134 | DBMET02134 | |
| 0.019 | 0.638 | 0.169 | Antiamyloidogenic | 0.169 0.124 DBMET02133 | DBMET02133 | |
| 0.005 | 0.662 | 0.081 | Inducible nitric-oxide synthase inhibitor | 0.081 0.061 DBMET02134 | DBMET02134 | |
| 0.067 | 0.733 | 0.186 | 5 Hydroxytryptamine uptake stimulant | 0.186 0.182 DBMET02134 | DBMET02134 | |
| 0.018 | 0.753 | 0.196 | Transcription factor STAT inhibitor | 0.196 0.145 DBMET02134 | DBMET02134 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |